1. The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain
   Giulia Donvito et al, 2017, Neuropsychopharmacology CrossRef
2. Cannabinoids for the treatment of rheumatic diseases — where do we stand?
   Daphna Katz-Talmor et al, 2018, Nat Rev Rheumatol CrossRef
3. Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease
   Marco Gentili et al, 2018, Pharmacological Research CrossRef
4. Protective effects of specific cannabinoid receptor 2 agonist GW405833 on concanavalin A-induced acute liver injury in mice
   Ze-bing Huang et al, 2019, Acta Pharmacol Sin CrossRef
5. Cannabinoids in Autoimmune and Rheumatic Diseases
   Luca Navarini et al, 2019 CrossRef
6. Role of cannabinoid receptor 1 and the peroxisome proliferator-activated receptor α in mediating anti-nociceptive effects of synthetic cannabinoids and a cannabinoid-like compound
   Mohammad Alsalem et al, 2019, Inflammopharmacol CrossRef
7. Medical cannabis and cannabinoids in rheumatology: where are we now?
   Piercarlo Sarzi-Puttini et al, 2019, Expert Review of Clinical Immunology CrossRef
8. Dose‐Dependent Cannabidiol‐Induced Elevation of Intracellular Calcium and Apoptosis in Human Articular Chondrocytes
   Martina Winklmayr et al, 2019, J. Orthop. Res CrossRef
9. Tendon Homeostasis: Overview
   Angela W. Ilaltdinov et al, 2020 CrossRef
10. Exosomal miR-9-5p secreted by bone marrow–derived mesenchymal stem cells alleviates osteoarthritis by inhibiting syndecan-1
    Zhe Jin et al, 2020, Cell Tissue Res CrossRef
11. Matrix Metalloproteinase-3 induces proteoglycan degradation in gouty arthritis model
    Le Shi et al, 2020, Gene CrossRef
12. The Current Evidence for Marijuana as Medical Treatment
    J. Stewart Buck et al, 2020 CrossRef
13. EZH2 is associated with cartilage degeneration in osteoarthritis by promoting SDC1 expression via histone methylation of the microRNA-138 promoter
    Jian Wang et al, 2021, Lab Invest CrossRef
14. In Vitro Effects of Low Doses of β-Caryophyllene, Ascorbic Acid and d-Glucosamine on Human Chondrocyte Viability and Inflammation
    Elena Mattiuzzo et al, 2021, Pharmaceuticals CrossRef
15. Knowledge and Opinion on Cannabinoids Among Orthopaedic Traumatologists.
    Garwin Chin et al, 2021, J Am Acad Orthop Surg Glob Res Rev CrossRef
16. Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review
    Marta Bryk et al, 2021, Pharmacol. Rep CrossRef
17. Interleukin‐34 Reprograms Glycolytic and Osteoclastic Rheumatoid Arthritis Macrophages via Syndecan 1 and Macrophage Colony‐Stimulating Factor Receptor
    Katrien Van Raemdonck et al, 2021, Arthritis Rheumatol CrossRef
18. Cannabis for Rheumatic Disease Pain: a Review of Current Literature
    William Benjamin Nowell et al, 2022, Curr Rheumatol Rep CrossRef
19. HU308 Mitigates Osteoarthritis by Stimulating Sox9‐Related Networks of Carbohydrate Metabolism
    Idan Carmon et al, 2022, J of Bone & Mineral Res CrossRef
20. Perceptions and Opinions on Cannabidiol in the Orthopaedic Sports Medicine Community
    Zachary I. Li et al, 2023, Orthopaedic Journal of Sports Medicine CrossRef